Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Peptide Laws UK Legal Status Sourcing: Research vs. Therapeutic Use Comparison

Research-grade peptides (laboratory use) Legal with proper labelling Minimal. Customs review only Certificate of analysis, research intent declaration, supplier GMP compliance None for most peptides; automatic approval with compliant documentation Lowest regul

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Research-grade peptides (laboratory use)
  • Legal with proper labelling
  • Minimal. Customs review only
  • Certificate of analysis, research intent declaration, supplier GMP compliance
  • None for most peptides; automatic approval with compliant documentation
  • Lowest regulatory barrier. Suitable for institutional research, preclinical studies, and method development when sourced from licensed suppliers like Real Peptides
  • Peptides marketed for human therapeutic use
  • Requires MHRA marketing authorisation
  • Full pharmaceutical oversight
  • Clinical trial data, manufacturing license, batch release testing
  • Prohibited without authorisation. Customs will seize
  • Not accessible to individual researchers. Requires pharmaceutical company sponsorship
  • Compounded peptides from UK pharmacies
  • Legal only with prescription
  • MHRA Section 10 exemption applies
  • Prescription from UK-licensed prescriber, pharmacy registration
  • Limited to specific peptides approved for compounding
  • Legally restricted to patient-specific orders. Not available for research purposes
  • Peptides sold as supplements or wellness products
  • Illegal under Medicines Act
  • Active enforcement. Frequent supplier prosecutions
  • Not applicable. Product category is prohibited
  • Automatic customs seizure if identified
  • High legal risk. UK authorities prosecute suppliers marketing peptides as supplements